In the context of the ongoing outbreak of Shiga toxin-producing E. coli (STEC) that affects by now citizens from 13 EU member states, it is crucial not only to align the efforts regarding investigation and control of the outbreak but also to share knowledge among practitioners across Europe on the patho-physiological and clinical characteristics of infection caused by this unusual epidemic strain, and review patient management options.
On 9 June, ECDC will be hosting a technical side-event to the United Nations High-Level Meeting on AIDS 2011. The event will highlight how countries and regions with differing epidemiology could improve their responses to HIV/AIDS.
In his speech before the EU Health Ministers recently, ECDC Director Marc Sprenger outlined several public health measures to meet the measles elimination target by 2015 in Luxembourg.
European Union countries face the challenge of how to best allocate limited resources in healthcare protection and disease prevention to achieve maximum results. Measurement of the burden of diseases provides important evidence for health policy formulation.
Today, the German authorities published a press release on the current Shiga toxin-producing E.coli outbreak. In their joint statement they recommended in particular to abstain from eating raw sprouts.
Cysticercosis is the infection by the larval form of Taenia solium. The authors describe 9 cases of neurocysticercosis - diagnosed in Israeli travellers during a period of 15 years.
Heightened surveillance of acute febrile illness in China since 2009 has led to the identification of a severe fever with thrombocytopenia syndrome (SFTS).
A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight) or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis.